Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride treatment for three years changes certain polyamine levels in the blood but not in urine.

Polycystic Ovary Syndrome (PCOS) is not very common among Iranian women, but it's important to prevent it because of the risk of heart disease and infertility.

The Polish medical societies have redefined metabolic syndrome and recommend lifestyle changes, certain medications, and possibly bariatric surgery for treatment. They also discuss managing related health conditions.

Hispanic women with PCOS are more likely to have liver diseases like NAFLD and NASH.

The 2023 guideline for PCOS suggests using updated diagnostic criteria, assessing related health risks, and recommends lifestyle changes and specific treatments for symptoms and fertility issues.

The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.

Combining yoga and certain herbs can effectively manage PCOS symptoms and improve quality of life.

Women with PCOS are much more likely to experience depression.

Some women with PCOS have rare genetic variants linked to the condition.

Multi-omics techniques help understand the molecular causes of androgenetic alopecia.

Combining micro-needling, LED therapy, and growth factors with Finasteride® significantly improves hair growth.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Higher testosterone and DHT levels are linked to hair loss in men, but not to prostate cancer risk.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Cells from balding scalps have more androgen receptors than cells from non-balding scalps.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Prenatally androgenized ewes can model increased hair diameter in women with PCOS.

The chapter explains the causes of excessive hair growth and masculinization in women and how to measure hormone levels related to these conditions.

The document concludes that hirsutism can be managed with various treatments tailored to the individual, potentially improving quality of life.

Cyproterone acetate implants were more effective at reducing facial hair and improving skin in severe hirsutism than oral treatment.

Hair loss in women not always linked to increased oil production; other factors may be involved.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

Low-dose finasteride reduces excessive hair growth in teenage girls safely and affordably.

Myo-inositol supplements may improve insulin sensitivity and help with conditions like PCOS and gestational diabetes, but more research is needed.

Severe and early hair loss may indicate a higher risk of heart disease.

Female-pattern baldness is not linked to more migraines.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

Finasteride safely lowers DHT levels without affecting testosterone.